E P Wright|M A Knowles - JoVE Visualize

Showing results (71-80 of 130) with videos related to

Pageof 13

Sort By:

Cancer Research|January 1, 1983

Long-term organ culture of normal human bladderM A Knowles, A Finesilver, A E Harvey, et al.

The Journal of Infection|March 1, 1983

Pulmonary actinomycosis simulating a bronchial neoplasmE P Wright, K Holmberg, J Houston, et al.

Asia-Pacific Journal of Public Health|February 16, 2012

Problem-based learning (PBL) and public health: an initial exploration of perceptions of PBL in VietnamJohn W Grisham, Alexandra L C Martiniuk, Joel Negin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987

Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapyJ D Hainsworth, E P Wright, G F Gray, et al.

International Journal of Cancer|March 12, 1993

Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progressionH J Xu, P Cairns, S X Hu, et al.

Health Policy (Amsterdam, Netherlands)|August 6, 1995

The pursuit of equity: a health sector case study from VietnamN T Hein, L T Ha, S B Rifkin, et al.

Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987

Morphological changes and serological reactions in cultured Leishmania donovani promastigotesE A Mohammed, E P Wright, J J Laarman, et al.

The Journal of Arthroplasty|March 11, 1998

Successful 1-stage exchange total knee arthroplasty for fungal infectionG P Selmon, R N Slater, J A Shepperd, et al.

Human Molecular Genetics|September 1, 1995

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancerM P Williamson, P A Elder, M E Shaw, et al.

Genomics|September 23, 1997

Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancerS M Bell, M Shaw, Y S Jou, et al.

Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:

Pageof 13

Cancer Research|January 1, 1983

Long-term organ culture of normal human bladderM A Knowles, A Finesilver, A E Harvey, et al.

The Journal of Infection|March 1, 1983

Pulmonary actinomycosis simulating a bronchial neoplasmE P Wright, K Holmberg, J Houston, et al.

Asia-Pacific Journal of Public Health|February 16, 2012

Problem-based learning (PBL) and public health: an initial exploration of perceptions of PBL in VietnamJohn W Grisham, Alexandra L C Martiniuk, Joel Negin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987

Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapyJ D Hainsworth, E P Wright, G F Gray, et al.

International Journal of Cancer|March 12, 1993

Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progressionH J Xu, P Cairns, S X Hu, et al.

Health Policy (Amsterdam, Netherlands)|August 6, 1995

The pursuit of equity: a health sector case study from VietnamN T Hein, L T Ha, S B Rifkin, et al.

Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987

Morphological changes and serological reactions in cultured Leishmania donovani promastigotesE A Mohammed, E P Wright, J J Laarman, et al.

The Journal of Arthroplasty|March 11, 1998

Successful 1-stage exchange total knee arthroplasty for fungal infectionG P Selmon, R N Slater, J A Shepperd, et al.

Human Molecular Genetics|September 1, 1995

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancerM P Williamson, P A Elder, M E Shaw, et al.

Genomics|September 23, 1997

Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancerS M Bell, M Shaw, Y S Jou, et al.

Pageof 13